Overholser and colleagues discuss the role of
endocrine therapy to reduce risk for breast cancer, and cite interesting data from patients who developed premature ovarian failure due to ovarian irradiation or alkylating chemotherapeutic
agents, which demonstrates that these patients were at decreased risk for developing subsequent breast cancer.